Breaking Morgan Freeman to Release New Album Celebrating Blues Music Syrian Court Sentences Assad and Brother to Death in Absentia Drone Strike Causes Major Fire at Libyan Oil Refinery Russian Aerial Attacks Kill Civilians in Ukraine; Zelenskyy Cites North Korean Missile Aid Mount Bromo Wildfire Largely Contained After Scorching National Park

Tuesday August 11, 2026

Section

Trending

Press Release

Consortium launches Project SEAN to advance electric aviation across Scotland’s Highlands and Islands

Bristow Group · Jul 23

Press Release

Cyberhaven Extends Data and AI Security Platform with Support for ChatGPT Enterprise and Claude Compliance API Integrations

Cyberhaven · Jul 23

Press Release

Navitas and Magnachip Announce Strategic Partnership to Accelerate High-Voltage and Ultra-High-Voltage Silicon Carbide Adoption

Navitas Semiconductor Corporation · Jul 23

Press Release

USCB Financial Holdings, Inc. Surpasses $3 Billion in Assets with 14.6% Annualized Linked-Quarter Loan Growth; Achieves Q2 2026 EPS of $0.49, 3.49% Net Interest Margin, ROAA of 1.26%, and ROAE of 15.90%

U.S. Century Bank · Jul 23

National - Breaking

Trump Administration Plans Significant Tariffs on Imported Generic Drugs

SignalNewsAI · Jul 23

Health

FDA Advisory Committee Recommends Specialty Pharmacy Access for Two Peptides, Diverging from FDA Staff Concerns

SignalNewsAI · Jul 23

National - Breaking

Department of Education Rescinds Rule on Discriminatory School Policies

SignalNewsAI · Jul 23

Press Release

Albemarle Appoints Eduardo Bartolomeo to Board of Directors

Albemarle Corporation · Jul 23

Press Release

Colossal Announces Return of Third Annual Baby of the Year® Competition

Colossal · Jul 23

Press Release

Moody’s Updates Phillips Edison & Company Outlook to Positive

Phillips Edison & Company, Inc. · Jul 23

Press Release

Arrcus and UfiSpace Deliver a Production-Ready AI Networking Solution for AMD-Powered AI Infrastructure

Business Wire · Jul 23

Press Release

Selective Reports Second Quarter 2026 Results

Business Wire · Jul 23

$Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)$ Press Release

Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Business Wire · Jul 23

← Previous 1 … 1,140 1,141 1,142 … 1,146 Next →